Zimmer Biomet Holdings, Inc. logo
Zimmer Biomet Holdings, Inc. (ZBH)
Compare

Zimmer Biomet Holdings, Inc. (ZBH) Free Cash Flow (FCF): $1.84B

The free cash flow (FCF) for Zimmer Biomet Holdings, Inc. (ZBH) is $1.84B. It is above its 12-month average by 40.38% ($1.31B).

ZBH Free Cash Flow (FCF) Chart

ZBH Free Cash Flow (FCF)
$1.47B+28.87% 1Y
Zoom

ZBH Average Free Cash Flow (FCF) Chart

ZBH Current vs Average Free Cash Flow (FCF) Chart

ZBH Free Cash Flow (FCF) Metrics

FREE CASH FLOW (FCF)

$1.84B

FREE CASH FLOW (FCF) AVG TTM

$1.31B

FREE CASH FLOW (FCF) AVG 3Y

$1.22B

FREE CASH FLOW (FCF) AVG 5Y

$1.22B

FREE CASH FLOW (FCF) AVG 10Y

$1.24B

FREE CASH FLOW (FCF) AVG 15Y

$1.16B

FREE CASH FLOW (FCF) AVG 20Y

$1.06B

CURRENT VS TTM AVG

+40.38%

CURRENT VS 3Y AVG

+50.78%

CURRENT VS 5Y AVG

+50.68%

CURRENT VS 10Y AVG

+48.12%

CURRENT VS 15Y AVG

+57.76%

CURRENT VS 20Y AVG

+73.57%

FCF Analysis

Free Cash Flow (TTM)

$1.84B

FCF Yield

10.66%

Price/FCF

9.4

Formula: FCF = Operating Cash Flow - Capital Expenditures

Why FCF matters:

  • Shows actual cash available (not accounting earnings)
  • Funds dividends, buybacks, and debt reduction
  • Less susceptible to accounting manipulation than net income
  • Key metric for DCF valuation models

Zimmer Biomet Holdings, Inc. Free Cash Flow (FCF) Formula & Definition

Free Cash Flow represents the cash a company generates after accounting for capital expenditures. It's the cash available for dividends, buybacks, debt reduction, or reinvestment.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Zimmer Biomet Holdings, Inc. Free Cash Flow (FCF) FAQ

What is the free cash flow (FCF) for Zimmer Biomet Holdings, Inc. (ZBH)?
The free cash flow (FCF) for ZBH stock is $1.84B.
What is the TTM average free cash flow (FCF) for Zimmer Biomet Holdings, Inc. (ZBH)?
The TTM average free cash flow (FCF) for ZBH stock is $1.31B.
What is the 3Y average free cash flow (FCF) for Zimmer Biomet Holdings, Inc. (ZBH)?
The 3Y average free cash flow (FCF) for ZBH stock is $1.22B.
What is the 5Y average free cash flow (FCF) for Zimmer Biomet Holdings, Inc. (ZBH)?
The 5Y average free cash flow (FCF) for ZBH stock is $1.22B.
What is the 10Y average free cash flow (FCF) for Zimmer Biomet Holdings, Inc. (ZBH)?
The 10Y average free cash flow (FCF) for ZBH stock is $1.24B.
What is the 15Y average free cash flow (FCF) for Zimmer Biomet Holdings, Inc. (ZBH)?
The 15Y average free cash flow (FCF) for ZBH stock is $1.16B.
What is the 20Y average free cash flow (FCF) for Zimmer Biomet Holdings, Inc. (ZBH)?
The 20Y average free cash flow (FCF) for ZBH stock is $1.06B.

Zimmer Biomet Holdings, Inc. Free Cash Flow (FCF) History

DATEFREE CASH FLOW (FCF)
2025-12-31$1.47B
2024-12-31$1.14B
2023-12-31$1.19B
2022-12-31$1.07B
2021-12-31$1.35B
2020-12-31$1.09B
2019-12-31$1.18B
2018-12-31$1.58B
2017-12-31$1.43B
2016-12-31$1.45B
2015-12-31$682.10M
2014-12-31$915.60M
2013-12-31$863.10M
2012-12-31$1.04B
2011-12-31$1.06B
2010-12-31$1.11B
2009-12-31$852.90M
2008-12-31$440.80M
2007-12-31$753.20M
2006-12-31$772.40M
2005-12-31$772.90M
2004-12-31$761.40M
2003-12-31$336.30M
2002-12-31$186.50M
2001-12-31$117.10M
2000-12-31$203.40M
1999-12-31$147.00M
1998-12-31$179.00M

About Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc. (ZBH), along with its global subsidiaries, operates as a leading player in the musculoskeletal healthcare sector. The company extends its reach across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. ZBH is responsible for the design, manufacturing, and marketing of a wide array of orthopedic reconstructive solutions, including prominent knee and hip replacement systems. Their offerings also encompass Specialized Enabling Technologies (S.E.T.) products, which cover areas such as sports medicine, biologics, foot and ankle care, extremity treatments, and trauma management. Furthermore, the company provides medical devices and surgical instruments specifically for spinal conditions, alongside products for facial and cranial reconstruction. A unique part of their portfolio includes systems designed to stabilize and fixate chest bones, facilitating recovery or reconstruction following open-heart surgery, traumatic injuries, or congenital chest deformities. The company's product lines also feature a comprehensive range of dental solutions, such as reconstructive implants, prosthetics, and regenerative materials. Additionally, they are involved in robotic surgical systems, general surgical instruments, and bone cements. These advanced products and solutions are primarily utilized to address conditions in patients suffering from disorders or injuries affecting bones, joints, and their associated soft tissues. Zimmer Biomet caters to a broad clientele, including orthopedic, neuro-, and oral surgeons, dentists, hospitals, independent distributors, healthcare suppliers, and various other medical specialists. Their network further encompasses agents, healthcare purchasing organizations, and group buying alliances. Originally established in 1927, the enterprise was initially known as Zimmer Holdings, Inc., before rebranding as Zimmer Biomet Holdings, Inc. in June 2015. Its corporate headquarters are situated in Warsaw, Indiana.

Warsaw, IN
17,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Ivan Tornos